<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>63</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>11</Month>
        <Day>17</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Blood Indoxyl Sulfate and TGF-&#x3B2;1 Protein and mRNA Levels in Chronic Kidney Disease: Updated Insights</title>
    <FirstPage>231</FirstPage>
    <LastPage>236</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Nazarinasi</LastName>
        <affiliation locale="en_US">Department of Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Siavash</FirstName>
        <LastName>Gerayeshnejad</LastName>
        <affiliation locale="en_US">Department of Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nasrin</FirstName>
        <LastName>Dashti</LastName>
        <affiliation locale="en_US">Department of Laboratory Science, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Khosrow</FirstName>
        <LastName>Rahbar</LastName>
        <affiliation locale="en_US">Department of Nephrology and Urology, Mehrad Hospital, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>05</Month>
        <Day>24</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>08</Month>
        <Day>27</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Chronic kidney disease (CKD) is characterized by systemic inflammation and the accumulation of uremic toxins such as indoxyl sulfate (IS), which induces fibrogenic signaling via transforming growth factor-beta 1 (TGF-&#x3B2;1). Forty CKD patients and ten healthy controls were enrolled. IS was measured by HPLC, TGF-&#x3B2;1 protein by ELISA, and TGF-&#x3B2;1 mRNA by RT-qPCR in PBMCs. IS and TGF-&#x3B2;1 mRNA levels increased significantly with CKD stage, particularly in stages 3 and 4. TGF-&#x3B2;1 mRNA correlated with IS levels (R=0.4, P&lt;0.01), while TGF-&#x3B2;1 protein levels were associated with platelet count (R=0.817, P&lt;0.001). TGF-&#x3B2;1 mRNA in PBMCs may serve as an early biomarker of CKD-related fibrosis. IS is a key uremic toxin influencing fibrogenic gene expression.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/11674</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/11674/5975</pdf_url>
  </Article>
</Articles>
